Details for New Drug Application (NDA): 080123
✉ Email this page to a colleague
The generic ingredient in LANTRISUL is trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). Additional details are available on the trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) profile page.
Summary for 080123
Tradename: | LANTRISUL |
Applicant: | Lannett |
Ingredient: | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 167MG/5ML;167MG/5ML;167MG/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription